Fig. 3. Reduction of JNK and c-Jun phosphorylation in
M1+/
KDJ1-/-
eyelid epithelium. (A) The
M1+/
KDJ1-/-
and
M1+/
KDJ2-/-
fetuses at E15.5 were examined by immunohistochemistry for the phospho- and
total JNK and c-Jun, phospho-EGFR (p-EGFR), phospho-ERK (p-ERK) and
phospho-Elk (p-Elk). Levels of only p-JNK and p-c-Jun were significantly
reduced in the developing eyelid epithelium of the
M1+/
KDJ1-/-
fetuses. Scale bars: 50 µm. (B) Quantitative summary of the
percentage of p-JNK- and p-c-Jun-positive cells in suprabasal epithelial
layers of the developing eyelids in various gene knockout fetuses. Data are
mean ± s.d. of at least four fetuses of each genotype examined. Only
the
M1+/
KDJ1-/-
fetuses showed significant (*P<0.01) reduction in p-JNK
and p-c-Jun compared with wild-type fetuses. (C) E15.5
Jnk1-null (J1-/-) and Jnk2-null
(J2-/-) fetuses were subjected to X-Gal staining to detect
the target gene promoter-driven β-galactosidase expression.
X-Gal-positive cells were detected in the entire embryonic body of E15.5
fetuses. Arrowheads indicate the developing eyelid tip.